Diffusion Pharmaceuticals Inc (DFFN)

Etorro trading 970x250
Diffusion Pharmaceuticals Inc (DFFN) Logo

About Diffusion Pharmaceuticals Inc

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body’s ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company is also developing DFN-529, a phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin pathway inhibitor. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia. Address: 1317 Carlton Avenue, Charlottesville, VA, United States, 22902

Diffusion Pharmaceuticals Inc News and around…

Latest news about Diffusion Pharmaceuticals Inc (DFFN) common stock and company :

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
26 Oct, 2021 FinancialContent

Gainers Ocugen (NASDAQ:OCGN) stock increased by 31.15% to $12.25 during Tuesday's pre-market session. The market ...

12 Health Care Stocks Moving In Tuesday's After-Market Session
19 Oct, 2021 FinancialContent

Gainers Sesen Bio (NASDAQ:SESN) stock moved upwards by 17.82% to $1.19 during Tuesday's after-market session. This security traded ...

7 Biotech Penny Stocks With Huge Catalysts Coming in 2022
14 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips With a new year fast approaching, these biotech penny stocks may benefit from the shifting winds in the broader healthcare market. The post 7 Biotech Penny Stocks With Huge Catalysts Coming in 2022 appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
12 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

12 Health Care Stocks Moving In Wednesday's After-Market Session
15 Sep, 2021 FinancialContent

Gainers Larimar Therapeutics (NASDAQ:LRMR) shares rose 10.53% to $13.75 during Wednesday's after-market session. The ...

We're Not Very Worried About Diffusion Pharmaceuticals' (NASDAQ:DFFN) Cash Burn Rate
10 Sep, 2021 Yahoo! Finance

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

Diffusion Pharmaceuticals Issues Letter to Shareholders
09 Sep, 2021 FinancialContent
Diffusion Pharmaceuticals to Present at the 23rd Annual H.C. Wainwright Global Investment Conference
08 Sep, 2021 FinancialContent

Conference to Take Place Virtually, September 13-15, 2021

12 Health Care Stocks Moving In Monday's After-Market Session
31 Aug, 2021 FinancialContent

Gainers Sonnet BioTherapeutics (NASDAQ:SONN) stock moved upwards by 20.91% to $0.68 during Monday's after-market session. Today's ...

Diffusion Pharmaceuticals Announces Clearance of IND Application for TSC by FDA’s Pulmonology, Allergy, and Critical Care Division
30 Aug, 2021 FinancialContent
12 Health Care Stocks Moving In Thursday's Pre-Market Session
19 Aug, 2021 FinancialContent

Gainers Sonnet BioTherapeutics (NASDAQ:SONN) shares increased by 97.28% to $1.47 during Thursday's pre-market ...

DFFN: Initial Indication for TSC to be Announced 4Q21…
19 Aug, 2021 Yahoo! Finance

By David Bautz, PhD NASDAQ:DFFN READ THE FULL DFFN RESEARCH REPORT Business Update Preparing for Two Additional Oxygenation Trials in 4Q21 Diffusion Pharmaceuticals, Inc. (NASDAQ:DFFN) is in the process of evaluating its lead development compound, trans sodium crocetinate (TSC), in a series of oxygenation trials to better understand TSC’s mechanism of action and clinical potential. The company

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
18 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
17 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Diffusion Pharmaceuticals Reports Q2 Financial Results and Provides Business Update
11 Aug, 2021 FinancialContent
10 Biotech Penny Stocks to Buy According to Reddit
06 Aug, 2021 Yahoo! Finance

In this article, we discuss the 10 biotech penny stocks to buy according to Reddit. If you want to skip our detailed analysis of these stocks, go directly to the 5 Biotech Penny Stocks to Buy According to Reddit. Innovation and advancements in science and technology over the past few decades have transformed the field […]

The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
16 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

12 Health Care Stocks Moving In Thursday's After-Market Session
15 Jul, 2021 FinancialContent

Gainers Akebia Therapeutics (NASDAQ:AKBA) shares moved upwards by 3.31% to $3.43 during Thursday's after-market session. Akebia ...

The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
15 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

12 Health Care Stocks Moving In Friday's After-Market Session
09 Jul, 2021 FinancialContent

Gainers Delcath Systems (NASDAQ:DCTH) stock increased by 8.87% to $11.9 during Friday's after-market session. This security traded ...

Making a List of Penny Stocks to Buy? Here’s 7 to Watch in Summer 2021
07 Jul, 2021 FinancialContent
DFFN: TSC Causes Dose Dependent Increase in Tissue Oxygenation in TCOM Trial…
06 Jul, 2021 Yahoo! Finance

By David Bautz, PhD NASDAQ:DFFN READ THE FULL DFFN RESEARCH REPORT Business Update Positive Trends Seen in TCOM Trial On June 30, 2021, Diffusion Pharmaceuticals, Inc. (NASDAQ:DFFN) announced topline results from the Phase 1 transcutaneous oxygen monitoring (TCOM) study of its lead development product trans sodium crocetinate (TSC). This study was designed to evaluate the exposure-reponse

7 Trending Penny Stocks That You Need to Know About in July 2021
30 Jun, 2021 FinancialContent
Diffusion Pharma's TSC Shows Encouraging Effects On Oxygenation
30 Jun, 2021 Yahoo! Finance

Diffusion Pharmaceuticals Inc (NASDAQ: DFFN) has announced topline results from the Phase 1 trial of its lead product candidate, trans sodium crocetinate (TSC). In the trial, transcutaneous oxygen monitoring (TCOM) was used to measure the direct pharmacodynamic effects of TSC on peripheral tissue oxygenation in healthy volunteers. Topline results were based upon analyses of primary endpoint data, which indicate, as compared to placebo, a positive dose-response trend in TCOM readings. Due to the

Diffusion Pharmaceuticals Reports Positive Trend in Oxygenation from TCOM Trial
30 Jun, 2021 FinancialContent

Trial Dosed Healthy Volunteers with Trans Sodium Crocetinate

Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
28 Jun, 2021 FinancialContent

Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentations

Best Penny Stocks To Buy On Robinhood Now? 12 To Watch This Week
27 Jun, 2021 FinancialContent
Virtual Conference for Life Sciences Companies Broadcast Live June 24th, 2021
21 Jun, 2021 FinancialContent

Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com

Diffusion Pharmaceuticals to Webcast Live at Life Sciences Investor Forum
21 Jun, 2021 FinancialContent

Presentation Scheduled for June 24, 2021 at 11:30 a.m., EDT

Diffusion Pharmaceuticals Reminds Stockholders to Vote Shares In Advance of Annual Meeting
18 Jun, 2021 FinancialContent

Annual Meeting Scheduled for June 25, 2021, at 1 p.m. EDT

Diffusion Pharmaceuticals Inc (DFFN) is a NASDAQ Common Stock listed in , ,

970x250